CROI 2017

infohep news

• Treatment for people who use drugs

  Hepatitis C treatment can be provided successfully at syringe programme sites

  Liz Highleyman / 18 April 2017

  Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City, researchers reported at the recent ...

• Transmission, epidemiology and prevention

  Study finds higher than expected hepatitis C prevalence among HIV-negative gay men in Amsterdam PrEP programme

  Liz Highleyman / 11 April 2017

  An unexpectedly high number of HIV-negative gay and bisexual men taking pre-exposure prophylaxis (PrEP) in Amsterdam were found to have hepatitis C virus (HCV) infection, suggesting HCV is being transmitted sexually between men ...

• Treatment for people living with HIV and HCV

  Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

  Liz Highleyman / 13 March 2017

  AbbVie's investigational glecaprevir/pibrentasvir treatment for hepatitis C is not expected to interact with or require dose adjustment when taken with commonly used antiretroviral regimens, offering a new option for people with HIV/hepatitis C ...

• Treatment for people living with HIV and HCV

  DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants

  Liz Highleyman / 07 March 2017

  People with HIV/hepatitis C virus (HCV) co-infection with liver cirrhosis or liver failure, and those who received liver transplants, saw high rates of sustained virological response using interferon-free direct-acting antiviral (DAA) therapy for ...

• Hepatocellular carcinoma (HCC)

  Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

  Liz Highleyman / 27 February 2017

  People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have an increased likelihood of developing hepatocellular ...

• Transmission and prevention

  New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

  Liz Highleyman / 17 February 2017

  A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already seen a dramatic decline in acute ...